When Should Women With Cancer Consider Fertility Preservation, and When Are Egg Freezing or Ovarian-Tissue Freezing Appropriate?

Overview: As cancer treatment improves, more young women can expect long-term survival, and planning for life after treatment is increasingly important. For women who have not had children or hope to have more children, assessing and preserving fertility before treatment is an important part of comprehensive cancer care.

Not everyone needs fertility preservation, and no single method suits everyone. Timing and method depend on age, cancer type, treatment regimen and how soon treatment must start. Patients with future reproductive plans should speak with their treating physician and reproductive-medicine team early, so that fertility protection can be considered without compromising cancer treatment.

Which women with cancer should consider fertility preservation?

Young women whose planned treatment may affect ovarian function should ask whether fertility preservation is appropriate.

This is especially relevant for women receiving chemotherapy, radiotherapy or HSCT, because these treatments may damage the ovaries and reduce the likelihood of natural pregnancy later.

The aim is not to delay cancer treatment, but to retain future reproductive possibilities while ensuring appropriate treatment of the disease.

Why is preservation recommended before treatment starts?

Chemotherapy, radiotherapy and transplant conditioning may cause irreversible damage to ovarian function.

Once treatment has begun, some ovarian follicles may already have been affected, potentially reducing the opportunity for preservation later.

Patients with future reproductive plans should therefore arrange assessment as early as possible before radiotherapy, chemotherapy or HSCT, and select a preservation method compatible with the treatment timetable.

Who may be suitable for egg freezing?

Egg (oocyte) cryopreservation is one of the more widely used methods of female fertility preservation.

Both egg quantity and quality decline with age. According to the source handbook, oocyte quality and in-vitro maturation rates are relatively high at ages 21–30. It generally recommends that women who need egg freezing consider doing so before age 35, because ovarian function and egg quality decline more rapidly afterward.

For women with cancer who hope to have children and have sufficient time before treatment, egg freezing is generally considered before chemotherapy, radiotherapy or HSCT to improve future reproductive opportunities.

Who may be better suited to ovarian-tissue freezing?

Egg freezing is not suitable for everyone.

For prepubertal girls who have not yet menstruated, mature eggs cannot ordinarily be collected, so ovarian-tissue cryopreservation may be considered.

The Chinese expert consensus on ovarian-tissue cryopreservation and transplantation identifies prepubertal patients, those who must start chemotherapy or radiotherapy too soon to complete ovarian stimulation, and selected patients with hormone-sensitive cancers as groups for whom the approach may be relevant.

After treatment, if the disease is stable and the patient has recovered sufficiently, frozen ovarian tissue may in selected cases be thawed and transplanted back to help restore hormonal function and, for some patients, fertility.

How long can frozen eggs and ovarian tissue be stored?

Many patients wonder whether material frozen now will remain usable in the future.

Eggs and ovarian tissue are generally stored in liquid nitrogen at approximately −196°C.

At this temperature, cellular metabolism is almost completely suspended, allowing long-term storage. The material can be thawed and considered for use when needed, with quality generally maintained under appropriate storage conditions.

Are children born using frozen eggs healthy?

This is an important concern for many patients.

Clinical experience accumulated over many years suggests that egg cryopreservation has a favorable safety profile.

According to the studies described in the source handbook, assisted reproduction using frozen eggs from younger women has shown fertilization and pregnancy rates similar to those using fresh eggs. Available research has not found a clear increase in chromosomal abnormalities, birth defects or developmental disorders in children born using frozen eggs.

Whether assisted reproduction is appropriate in a particular case must still be assessed by a reproductive-medicine specialist.

How should a fertility-preservation method be chosen?

No single preservation method is suitable for every patient.

Doctors consider age, marital status, whether childbearing is complete, cancer type, treatment regimen, time before treatment and personal reproductive wishes when developing an individualized plan.

Patients who hope to have children should raise this with their treating doctor promptly after diagnosis and obtain reproductive assessment early, so that an appropriate preservation opportunity is not missed.

Summary

Fertility protection should be considered early in the overall treatment plan for young women with cancer.

If treatment may affect ovarian function, assessment should take place before chemotherapy, radiotherapy or HSCT whenever possible. Egg freezing may be suitable for many eligible adult women; ovarian-tissue freezing may be considered for prepubertal girls or patients who cannot wait for ovarian stimulation.

The best approach is individualized through collaboration among hematology, oncology and reproductive-medicine teams.